Gentamicin implant - Innocoll

Drug Profile

Gentamicin implant - Innocoll

Alternative Names: Cogenzia; CollaRx; CollaRx® gentamicin topical - Innocoll; Collatamp EG; Collatamp G; Collatamp G topical; Cronocol; Duracoll; Garacol; Garacoll; Garamycin Schwamm; Gentacol; Gentacoll; Gentalyn; Gentamicin surgical implant - Innocoll; Gentamicin-collagen Topical; Gentimplant; INL-002; Sulmycin Implant; Sulmycin Implant E; Sulmycin Schwamm

Latest Information Update: 09 Nov 2016

Price : $50

At a glance

  • Originator Essex Chemie; Innocoll
  • Developer Innocoll; Premier Research Group
  • Class Aminoglycosides; Antibacterials; Small molecules
  • Mechanism of Action Protein 30S ribosomal subunit inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Postoperative infections
  • Phase III Diabetic foot ulcer

Most Recent Events

  • 03 Nov 2016 Topline efficacy and adverse events data from the phase III COACT-1 and COACT-2 studies in Diabetic foot ulcer (Combination therapy, In adults, In the elderly) released by Innocoll
  • 23 Jun 2016 Innocoll Holdings completes enrolment in the phase III COACT-1 trial for Diabetic foot ulcer in USA (NCT02427802)
  • 23 Jun 2016 Innocoll Holdings completes enrolment in the phase III COACT-2 trial for Diabetic foot ulcer in USA, Australia, Austria, Belgium, Czech Republic, Denmark, Germany, Hungary, Ireland, Italy, Netherlands, Poland, Slovakia, Spain, Sweden and the United Kingdom (NCT02447172)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top